期刊文献+

1例糖尿病足合并冠心病患者的药学监护 被引量:1

Pharmaceutical Care for a Patient with Diabetic Feet Combining Coronary Artery Disease:a Case Report
下载PDF
导出
摘要 目的:通过临床药师参与治疗1例糖尿病足合并冠心病患者的药学监护实践,了解糖尿病足合并冠心病患者治疗中的监护要点。方法:临床药师根据患者的病情变化,与临床医师讨论,提供相关治疗建议,共同制定针对性的治疗方案,并及时调整。结果:患者经过医生和药师的治疗和监护,糖尿病足逐渐好转,未出现不良反应。结论:临床药师参与临床治疗实践,有利于及时提出个体化的治疗计划,并提高药物治疗水平。 Objective: The key points of pharmaceutical care are to be grasped through the practice of clinical pharmacists in the treatment of 1 ease of diabetic feet with coronary artery disease. Methods: According to the changes of the patient's condition, clinical pharmacists provided treatment reeommendations, discussed with clinicians to develop targeted treatment programs and adjusted them timely. Results: Through the cooperative treatment and care by the doctors and the clinical pharmacists, the patient got better conditions with no further adverse reactions. Conclusion: Clinical pharmacists partaking in clinical treatment are valuable in the timely treatment of patients with adverse reactions and the level elevation of drug application.
出处 《药学与临床研究》 2013年第1期71-73,共3页 Pharmaceutical and Clinical Research
关键词 糖尿病足 临床药师 药学监护 Diabetic feet Clinical pharmacist Pharmaceutical care
  • 相关文献

参考文献6

  • 1中国2型糖尿病防治指南制订蚕见会.中国2划精球病防治指南(2007年版)[J].新医学,2010,4l(3):208.
  • 2Driver VR, Madsen J, Goodman RA. Reducing amputa- tion rates in patientswith diabetes atamilitary medical center: the limb preservation service model[J]. Diabetes Care, 2005, 28(2): 248-53.
  • 3Hottan N, Toyota T, Matsuoka K, el al. Clinical effh:a- cy of fidarestat, a novel ahlose reduelase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-hlind parallel group study[J]. Diabetes Care, 2001, 24 (10): 1776-82.
  • 4<应用抗菌药物防治外科感染的指导意见>撰写协作组,谭毓铨,黎沾良.应用抗菌药物防治外科感染的指导意见(草案)Ⅸ[J].中华外科杂志,2004,42(4):248-249. 被引量:3
  • 5Gotoh F, Tohgi H, Hirai S, el al. Cilostazol Stroke Prevention Study: a placebo-controlled double-blind trial for secondary prevention of cerebral infarction[J]. J Stroke Cerebrovtrc Dis, 2000, 9(4): 147.
  • 6Barta J, Sanganahnath SK, Kumamoto tt, et al. An- tiplatelel agents saqogrelate and lnstazol affect exper- imentally-induced ventrieular arrhylhmias and mortality [J]. Cardioasc 7bxicol, 2008, 8(3): 127-35.

二级参考文献1

共引文献2

同被引文献5

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部